PRKAB1 and Obesity: In the case of energy surplus, a decrease in AMPK activity leads to the downregulation of GLUT4 activity, which inhibits glucose uptake in insulin resistance and eventually leads to elevated blood sugar levels in patients with obesity and type 2 diabetes mellitus [103].